Mayu Higuchi
Musashino, 1808610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.
Journal: Diagnostics (Basel, Switzerland)
Published: March 30, 2026
Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds.
Journal: Journal of clinical medicine
Published: October 07, 2025
Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.
Journal: Diagnostics (Basel, Switzerland)
Published: May 23, 2024
Antimicrobial effects of epigallocatechin-3-gallate, a catechin abundant in green tea, on periodontal disease-associated bacteria.
Journal: Archives of oral biology
Published: April 30, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 27, 2023
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: October 17, 2023
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal of gastroenterology and hepatology
Published: October 10, 2023
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: October 01, 2023
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.
Journal: Quantitative imaging in medicine and surgery
Published: April 19, 2023
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.
Journal: Journal of viral hepatitis
Published: October 04, 2022
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
Journal: Internal medicine (Tokyo, Japan)
Published: September 07, 2022
Last Updated: 09/26/2026